Melissa Mae Carlton’s youngest daughter Molly has tragically passed away from suspected heart disease, one year after the death of the influencer’s daughter Abi.
“Christmas morning our sweet Molly girl and her sister Abi were reunited 💔,” she wrote on Instagram Friday.
“We are devastated. We are in disbelief. Confused and shocked. After a traumatic and heartbreaking day, we are exhausted and shaken,” Carlton added.
Ms Carlton said knowing how much Molly missed her sister “deeply” was “the one thing” that gave her “even a small sense of comfort”.
“She used to ask me, ‘Mom, when is Jesus coming back for Abi to come down?'” the internet personality explained.
Melissa, who is married to Tom Carlton, said her son Harry reassured her that Molly “got what she wanted” by being with Abi.
Melissa, who wasn’t Molly’s age, posted a heartbreaking photo of herself and Tom at her daughter’s hospital bedside, as well as several other sweet snaps.
The couple are also parents to a daughter named Lily.
In a follow-up post, Melissa shared an update on Molly’s death, which had sparked “speculation,” writing: “First of all, we are truly overwhelmed by the outpouring of support and prayers.”
Melissa explained that after paramedics quickly arrived and took Molly to a hospital 15 minutes away, she and Tom believed they were “united for the best conditions and the best outcome.”
She shared that a mild illness may have caused Molly’s “heart attack”, adding: “Her little body fought so hard. But we are told that this type of heart attack is something most people don’t survive.”
“It’s hard to even understand it,” Melissa added. “Doctors believe Molly had a genetic heart condition and suspect Abi may have had the same condition.”
she continued. “I’m sharing this because I think it could be important information for families who have experienced SUDC (sudden childhood death).”
Melissa admitted she was “never satisfied” with the answers she got when Abi died of sepsis in April 2024 at the age of nine.
The Carleton family is seeking “further answers in the near future” and plans to “conduct further genetic research.”
